#ASPChat Transcript

Healthcare social media transcript of the #ASPChat hashtag.
โ€“ ().
See #ASPChat Influencers/Analytics.

ProfileTweet
Melissa Johnson @IDPharmacist
@ASP_Chat Happy Thursday Night! #ASPchat
@Dr_Mike_Stevens
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD .A1 = what interventions/ strategies are best linked with decreases in GN antibiotic resistance #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD RE: Q1. I have been thinking about this all week. No one answer. Best so far is: What one intervention is most vital to preserving antibiotics for our children and the future? #ASPchat
CDC Emerging Infections @CDC_NCEZID
NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of languages! https://t.co/4NcSBetUtv #BeAntibioticsAware #ASPChat
Brandon Dionne @BWDionne
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD What is the most efficient antimicrobial stewardship strategy when resources are limited? Review all antibiotics (time intensive), targeted review (may miss opportunities), improve use of order sets/pathways (not always applicable). #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @CDC_NCEZID: NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of langโ€ฆ
Jamie Kisgen @KisgenUF
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD A1. Wow, tough questions. First thing that comes to mind is a large multicenter outcome study looking at different durations of therapy for gram-negative bacteremia. ๐Ÿค” #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@Dr_Mike_Stevens @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD So much overlap within this realm, is it a good thing or a bad thing? Probably a little of both and it all depends on the specific scenario, like everything in ID, lol! #ASPchat
Melissa Johnson @IDPharmacist
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD Which strategies are associated with the best real world outcomes? Ie ๐Ÿ”ฝ LOS, mortality, readmission rate, resistance, etc. #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @BWDionne: @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPhโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@BWDionne @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD Retrospective chart review... ๐Ÿคฎ #ASPchat
Julie Ann Justo @julie_justo
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD A1. What risk factors best predict antimicrobial resistance such that we can avoid broad-spectrum abx with confidence? #ASPchat #clinicaldecisionsupport
#ASPchat @ASP_Chat
Q2. What metric would you first ๐Ÿ‘€ look to for prioritizing antimicrobial stewardship research? Why? #ASPchat Note: This does not have to be your priority metric, rather is your starting point.
Jamie Kisgen @KisgenUF
@IDPharmacist @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD I would tag on to that, what are the differences in those same metrics between hospitals with and without robust stewardship programs in place. Could also stratify by hospital size, type (teaching/community), and region. #ASPchat
Todd McCarty ๐Ÿ’Š๐Ÿ‰๐Ÿ‘จโ€โš•๏ธ @TMcCarty2010
@ASP_Chat Time to change from empiric to targeted therapy (or none, if no infection found). #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @ASP_Chat: Q2. What metric would you first ๐Ÿ‘€ look to for prioritizing antimicrobial stewardship research? Why? #ASPchat Note: This doeโ€ฆ
Nick Bennett @nbennett04
Great point. How can we automate our EMR to help providers make informed decisions in situations that antibiotics have little utility-without alert fatigue? Has to be a home run ๐Ÿšจ/intervention. #ASPchat https://t.co/7yh4ERadZo
@Dr_Mike_Stevens
#ASPChat going for the gold with question #1! At this point it would be great if we could meaningfully collect real-time, (optimally) risk-adjusted, cross-compared Abx use data!! We are a long way from gold as a community
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunately this is one of the harder metrics to accurately measure. #ASPchat
Nick Bennett @nbennett04
@ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD A1: can it identify patients who can have their antibiotics stopped based on low risk profiles? #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @IDPharmacist: @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @โ€ฆ
CDC Emerging Infections @CDC_NCEZID
CDC released data in its AR Investment Map, which shows early progress by states to combat #AntibioticResistance โ€”when germs no longer respond to the drugs designed to kill them. https://t.co/vd6BFP3iaf #CDCfightsAR #ASPChat
Jamie Kisgen @KisgenUF
[REDACTED USER] @ASP_Chat @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD That is awesome. Canโ€™t wait to see the results! #ASPChat https://t.co/U1ix5hxItU
Melissa Johnson @IDPharmacist
@CDC_NCEZID This can be a valuable resource for stewards! #antimicrobialstewadship #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@julie_justo @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD We need one of these things from #StarTrek to help us detect MDROs at POC! #ASPchat https://t.co/4PlQeNUv8A
Melissa Johnson @IDPharmacist
[REDACTED USER] @BWDionne @ASP_Chat @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD Very Cool! Looking forward to seeing that. #ASPchat https://t.co/ecON1Vf8mq
Jamie Kisgen @KisgenUF
RT @IDstewardship: @ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunaโ€ฆ
Dr. Chris Braden @DrBraden_NCEZID
Healthcare Professionals: Register now for CDCโ€™s free #CE course on #antibiotic stewardship: https://t.co/HQg1LiCmdr #ASPChat https://t.co/nLc1YpRzfj
#ASPchat @ASP_Chat
Q3. Focusing on the ๐Ÿ˜ outpatient setting, what are your priority research areas for #antibiotic stewardship? #ASPchat https://t.co/vkeDn1jmXM
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@nbennett04 Agree. The future is clearly going to be heavily dependent upon technology. Alert fatigue is such an important issue too. Will be a major challenge to balance clinical skills of a doctor with the capacity of a system. Value of provider autonomy cannot be overshadowed. #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @ASP_Chat: Q3. Focusing on the ๐Ÿ˜ outpatient setting, what are your priority research areas for #antibiotic stewardship? #ASPchat httpsโ€ฆ
@Dr_Mike_Stevens
[REDACTED USER] .Definitely! We have been working on this in the hospital epidemiology community for decades and still there is room for improvement! Need to apply lessons learned on metrics from the infection prevention community to #AntimicrobialStewardship #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
An excellent resource indeed!!!! Especially for prepping future researchers ๐Ÿ‘ย #ASPchat https://t.co/ZGl06n6aJU
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: #ASPChat going for the gold with question #1! At this point it would be great if we could meaningfully collect real-tiโ€ฆ
Brandon Dionne @BWDionne
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Where do I even begin?...No, seriously, someone please tell me where we even begin with outpatient stewardship. #ASPChat https://t.co/BomR6lEXo5
Melissa Johnson @IDPharmacist
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. How can we do a better job of optimizing durations & appropriate prescribing of outpatient #antibiotic use given the large number of providers in play? #ASPchat
@Dr_Mike_Stevens
@BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Data! #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@nbennett04 @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @Dr_Mike_Stevens @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD That sounds really cool. I would totally invest in a "d/c antibiotics identifier" machine... it would also need to serve a dual purpose of treating prescriber anxiety ๐Ÿ˜‰ [REDACTED USER] #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @CDC_NCEZID: CDC released data in its AR Investment Map, which shows early progress by states to combat #AntibioticResistance โ€”when gerโ€ฆ
@Dr_Mike_Stevens
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Need to start with meaningful, normalized antibiotic data capture. Bonus points for risk adjustment and inter-facility cross comparison! If we can't measure it, we can't improve it #ASPChat
Jamie Kisgen @KisgenUF
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Data, Data, Data...we need a better understanding of the problem and identify real world, high impact interventions to move the needle. How do we give real time feedback to providers, peer to peer comparisons, and what are the best methods for educating the public? #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Q3. How can we change patient perceptions so that they put less pressure on prescribers and can leave satisfied without an antibiotic when it is not indicated (and can actually hurt them!). #ASPchat #LetYourDoctorDecide
@Dr_Mike_Stevens
@ASP_Chat .A2: The holy grail of #AntimicrobialStewardship is reducing the emergence of antibiotic resistance! If we focused here many other things would follow along (decreased LOS, morbidity, mortality, et cetera) #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@Dr_Mike_Stevens [REDACTED USER] I am surprised we haven't seen more talk about "stewardship bundles", kind of taking ideas from infection control. #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @BWDionne: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walโ€ฆ
@Dr_Mike_Stevens
@IDstewardship @nbennett04 @ASP_Chat [REDACTED USER] @accpinfdprn [REDACTED USER] @SIDPharm @CRE_REDUCE [REDACTED USER] [REDACTED USER] @PaulSaxMD @JGPharmD .Replace antibiotics as the anxiolytics of choice... #ASPChat
#ASPchat @ASP_Chat
Q4. If you had the resources to adress any one question at your practice site / institution, what would it be? ๐Ÿคทโ€โ™‚๏ธ๐Ÿคทโ€โ™€๏ธ #ASPchat https://t.co/AZmnoPBUdQ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @IDPharmacist: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacyโ€ฆ
@Dr_Mike_Stevens
[REDACTED USER] @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Well stated! The holy grail of Abx consumption metrics would be normalized, risk-adjusted, and would measure appropriateness of therapy! That's a tough call in a field where 40-60% of best practice is dictated by C-III level evidence though! #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @ASP_Chat: Q4. If you had the resources to adress any one question at your practice site / institution, what would it be? ๐Ÿคทโ€โ™‚๏ธ๐Ÿคทโ€โ™€๏ธ #ASPcโ€ฆ
Kristen Cincotta @kscincotta
RT @CDC_NCEZID: NEW from CDC's Be Antibiotics Aware: Materials for patients and healthcare professionals now available in a variety of langโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmaโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @KisgenUF: @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@ASP_Chat A4. How can I get outpatient antibiotic use data at institutional urgent care centers? #ASPchat
Brandon Dionne @BWDionne
@ASP_Chat What is the appropriate duration of antibiotics in neutropenic fever? There is some emerging evidence that you don't need to wait for engraftment, but some patients are still on cefepime for weeks waiting for resolution of neutropenia. #ASPChat
Nick Bennett @nbennett04
[REDACTED USER] @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3: how can rapid diagnostics be incorporated into ambulatory practice? Are they effective here? #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@Dr_Mike_Stevens @ASP_Chat We should do an #ASPchat on lab problems. Impact on reducing resistance only as good as your data... and the data ain't so good... especially outpatient... I [regretfully] think it's a lost cause 99% of the time...
@Dr_Mike_Stevens
@IDstewardship [REDACTED USER] .Definitely! We explored this a few years back but realized it's harder w/ #AntimicrobialStewardship (CLABSI, CAUTI, VAP are natural targets for bundles, outcome metrics like 'abx resistance' are less so...). I think there is a paper in here somewhere! #ASPChat
CDC Emerging Infections @CDC_NCEZID
Be Antibiotics Aware print materials now available to order via CDC-INFO On Demand! Visit https://t.co/VKhs5lCqJF and select โ€œantibiotic useโ€ from the drop-down menu. #antibiotics #ASPChat
@
What is the most (time) efficient way for pharmacists to identify individual patient misconceptions about abx when they pick up their Rx and then how can they clear the air on a case by case basis ? #ASPChat https://t.co/stbtrCffF6
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD Sustainability is something many studies completely fail to address. Great point that needs to be included if we are going to identify valuable interventions worth our investments. #ASPchat
@Dr_Mike_Stevens
@IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT solutions/ lab integration. I definitely picked up some tricks/ tips from a prior #ASPChat on integrating with the lab so think this is a great forum for it!
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@TheFebrileMuse @KisgenUF @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @Commpharmacy @cvspharmacy @Walgreens @mmPharmD What do you think of posters? How is the feedback from providers and nurses? Do they seem to work? Any notes on what seems to help make them more effective? #ASPchat
@Dr_Mike_Stevens
@IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Good point! 'Taking the foot of the gas' leads to 'regression to the mean' for most #AntimicrobialStewardship interventions; I think sustainability takes resources and longitudinal commitment #ASPChat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Getting the data and measuring the impact of patient interventions would be my priority. But also would like to explore how to create patient interventions that result in doctors NOT getting bad patient reviews for avoiding antibiotics. #ASPchat
#ASPchat @ASP_Chat
Q5. What do you perceive as priority research areas for helping ๐Ÿ•ต๏ธโ€โ™‚๏ธ๐Ÿ•ต๏ธโ€โ™€๏ธ regulatory bodies fairly asses institutional antimicrobial stewardship efforts? #ASPchat https://t.co/WVfpf6eJAr
David Ha @DHpharmd
@ASP_Chat A4. Does #AntimicrobialStewardship reduce #AntibioticResistance? #ASPchat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @IDstewardship: @ASP_Chat A2. When it comes down to it the thing that really matters is patient outcomes. I would start there. Unfortunaโ€ฆ
Brandon Dionne @BWDionne
@SoonToBePharmD Great point! How do we get community pharmacists (the biggest group of pharmacists) more involved in outpatient antimicrobial stewardship? Perhaps one of the biggest untapped resources? #ASPChat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @Dr_Mike_Stevens: @IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT sโ€ฆ
Brandon Dionne @BWDionne
RT @Dr_Mike_Stevens: @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @Theโ€ฆ
@Dr_Mike_Stevens
@IDstewardship @TheFebrileMuse @KisgenUF @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Providing meaningful education to patients on the dangers of antibiotics (resistance, et cetera) probably more useful than general education (bacterial vs viral infxns, et cetera). TVs in waiting areas, posters, whatever format probably less important than the message #ASPChat
@Dr_Mike_Stevens
@kevin_kls @SoonToBePharmD .True; to help facilitate optimal initial prescribing though need better deployment (as well as novel) rapid diagnostic testing! Hard to ask a patient who has one day of antibiotics left to change to a narrower antibiotic when a cx returns, practically #ASPChat
David Ha @DHpharmd
@BWDionne @SoonToBePharmD Yes! First things first, get community pharmacists real time access to patient information: diagnoses, labs, medication history, etc. Difficult to intervene on something when you know nothing about it #ASPchat #KnowledgeIsPower
Todd McCarty ๐Ÿ’Š๐Ÿ‰๐Ÿ‘จโ€โš•๏ธ @TMcCarty2010
@ASP_Chat Hopefully the recently developed SAR measurement from the @CDCgov proves helpful to fulfill this role and become widespread. #ASPchat
CDC Emerging Infections @CDC_NCEZID
Healthcare Professionals: Register now for CDCโ€™s free #CE course on #antibiotic stewardship: https://t.co/77W7PV9tHl #ASPChat https://t.co/bLf8uom5uF
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@nbennett04 [REDACTED USER] @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD How to incorporate rapid diagnostics into operations so they can be optimally employed is a topic of interest. Turn around time is a big deal. #ASPchat
Jamie Kisgen @KisgenUF
A5. We need more outcome data and benchmarks for setting goals. SAAR may be a start but we need more transparency on what best practice looks like. Its one thing to say a policy or protocol is in place, itโ€™s another to say they are making a difference. #ASPChat https://t.co/4u6E3CNPvC
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @CDC_NCEZID: Be Antibiotics Aware print materials now available to order via CDC-INFO On Demand! Visit https://t.co/VKhs5lCqJF and selecโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @SoonToBePharmD: What is the most (time) efficient way for pharmacists to identify individual patient misconceptions about abx when theyโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@ASP_Chat Also would invest in ideas to make rapid diagnosis of syndromes where antibiotics are most misused. #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: @IDstewardship @ASP_Chat This is a struggle! All #AntimicrobialStewardship work benefits from real-time, creative IT sโ€ฆ
@Dr_Mike_Stevens
@ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possible multicenter trials focused on the big question in stewardship (what strategies lead to decreased antibiotic resistance? What resources are needed to optimize these?)
Brandon Dionne @BWDionne
@DHpharmd @SoonToBePharmD I'm still not sure why at the very least the diagnosis/indication isn't a standard part of the prescription. #ASPChat
David Ha @DHpharmd
@DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD A3. Same old song but our PCPs need more TIME with patients to manage expectations and explain rationale. More time to be doctors not box checkers. This is the #1 through #100 root cause of #AntimicrobialStewardship issues in our experience #ASPchat
@Dr_Mike_Stevens
@IDstewardship @nbennett04 [REDACTED USER] @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvspharmacy @Walgreens @mmPharmD .Yes! Cost to the patient also an important consideration #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@ASP_Chat Where I trained the #1 question would be: How the heck are we supposed to dose this #colistin???? #ASPchat ...not sure if we will ever really know. Even describing a dose is a challenge!!! (IU, MG, CMS, CBA, ๐Ÿคข)
#ASPchat @ASP_Chat
Q6. When you need to pick a new #antibioticstewardship research or MUE question locally, where/who do you look to for guidance? #ASPchat https://t.co/2yPznK08Ot
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: @IDstewardship @kevin_kls @BWDionne @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @Theโ€ฆ
David Ha @DHpharmd
@ASP_Chat A6. Twitter #ASPchat
Cody L @CodyL44740165
@ASP_Chat A4. How much extra time are patients on sub/supratherapeutic doses of vancomycin due to improperly drawn trough levels? #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @DHpharmd: @ASP_Chat A4. Does #AntimicrobialStewardship reduce #AntibioticResistance? #ASPchat
Brandon Dionne @BWDionne
@DrJRMarcelin @ASP_Chat Also important that these tests are not cost-prohibitive. The one we have is restricted; by the time they get approval, they have often already ordered individual tests for half of the pathogens, so it is not cost-effective. #ASPChat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
@BWDionne @SoonToBePharmD Ditto. Community pharmacists really care about safe antibiotic use. When I talk to them they want to be involved and help, but they aren't being empowered like they could be and need support/direction. #ASPchat cc: @Commpharmacy
@Dr_Mike_Stevens
@ASP_Chat .It seems like great questions come up daily on the 'front lines' of #AntimicrobialStewardship! We keep a running list of possible projects and discuss monthly. Could also mine these #ASPChat sessions for great ideas, too!!
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@BWDionne @ASP_Chat And also easy to use and interpret! Essential for application in urgent care settings #ASPchat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @DHpharmd: @DrJRMarcelin @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFebrileMuse @Commpharmacy @cvโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @TMcCarty2010: @ASP_Chat Hopefully the recently developed SAR measurement from the @CDCgov proves helpful to fulfill this role and becomโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @Dr_Mike_Stevens: @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possiblโ€ฆ
David Ha @DHpharmd
@Dr_Mike_Stevens @ASP_Chat Agreed, honestly just asking "why is this happening", "how can we be better" in day to day practice reveal some of the most impactful research questions #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @DHpharmd: @BWDionne @SoonToBePharmD Yes! First things first, get community pharmacists real time access to patient information: diagnosโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @CDC_NCEZID: Healthcare Professionals: Register now for CDCโ€™s free #CE course on #antibiotic stewardship: https://t.co/77W7PV9tHl #ASPChโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @KisgenUF: A5. We need more outcome data and benchmarks for setting goals. SAAR may be a start but we need more transparency on what besโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: @ASP_Chat .A5: Going for the gold here (in the vein of tonight's #ASPChat!): Govt should put big $$$ into best possiblโ€ฆ
#ASPchat @ASP_Chat
๐Ÿ™Œ๐Ÿผ Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. ๐Ÿ—ฃ Heads up! Mark down June 13th for a chat on #IDintheED via a ๐Ÿ’ช๐Ÿฝ mega-collaboration between @accpinfdprn @SIDPharm @ASHP_EMPharm @accpemedprn @aaeminfo. More to come on that!
#ASPchat @ASP_Chat
Final tweet ๐Ÿ‘‰๐Ÿผ here is some data and discussion from @IDstewardship and [REDACTED USER] about the #ASPchat activities ๐Ÿ“ฒ https://t.co/grQioYdn6x Hope you find it interesting!!! https://t.co/qDfNPqp6JB
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @Dr_Mike_Stevens: @IDstewardship @nbennett04 [REDACTED USER] @ASP_Chat @theEDpharmacist @accpambuprn @Amb_Care_Mgmt [REDACTED USER] @krutu8 @TheFeโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @ASP_Chat: ๐Ÿ™Œ๐Ÿผ Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. ๐Ÿ—ฃ Heads up! Mark down Juneโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@ASP_Chat A5. Agreed with both. SAAR is promising. Need funding commitment from govt to assist institutions in achieving regulatory requirements. Especially critical access hospitals and outpatient clinics. How else are we expected to reduce inappropriate use by 50% by 2020? #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @ASP_Chat: Q6. When you need to pick a new #antibioticstewardship research or MUE question locally, where/who do you look to for guidancโ€ฆ
Brandon Dionne @BWDionne
RT @ASP_Chat: ๐Ÿ™Œ๐Ÿผ Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. ๐Ÿ—ฃ Heads up! Mark down Juneโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @DHpharmd: @ASP_Chat A6. Twitter #ASPchat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@ASP_Chat A6. Lots of great questions come up on rounds when I am the ID attending on hospital service #ASPchat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @DHpharmd: @Dr_Mike_Stevens @ASP_Chat Agreed, honestly just asking "why is this happening", "how can we be better" in day to day practicโ€ฆ
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @BWDionne: @DrJRMarcelin @ASP_Chat Also important that these tests are not cost-prohibitive. The one we have is restricted; by the timeโ€ฆ
David Ha @DHpharmd
@KisgenUF Agree ๐Ÿ’ฏ% here. Simply having passive protocols and policies without any real outcomes to show for it just furthers the "checking the box" approach, which can add time and cost, achieves no outcome and increases doubt in the system #ASPchat
David Ha @DHpharmd
RT @ASP_Chat: ๐Ÿ™Œ๐Ÿผ Thanks for joining the #ASPchat today and keeping it alive!!! The next one will be June 21st. ๐Ÿ—ฃ Heads up! Mark down Juneโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
Agree ๐Ÿ’ฏ. We have to somehow convince patients that we are on the same team when it comes to appropriate antibiotic use #ASPchat https://t.co/xrsbbmz5Wj
David Ha @DHpharmd
RT @ASP_Chat: Final tweet ๐Ÿ‘‰๐Ÿผ here is some data and discussion from @IDstewardship and [REDACTED USER] about the #ASPchat activities ๐Ÿ“ฒ https://t.co/gโ€ฆ
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
RT @ASP_Chat: Final tweet ๐Ÿ‘‰๐Ÿผ here is some data and discussion from @IDstewardship and [REDACTED USER] about the #ASPchat activities ๐Ÿ“ฒ https://t.co/gโ€ฆ
David Ha @DHpharmd
Yes, find that students' fresh, unadulterated, sometimes idealistic views of things can give them profound insights ๐Ÿ‘ #ASPchat https://t.co/h9ziw4QsZd
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @DrJRMarcelin: @ASP_Chat A6. Lots of great questions come up on rounds when I am the ID attending on hospital service #ASPchat
Bug Pharmacist ๐Ÿ’Š๐Ÿงซ Tim Gauthier @IDstewardship
RT @DHpharmd: Yes, find that students' fresh, unadulterated, sometimes idealistic views of things can give them profound insights ๐Ÿ‘ #ASPchaโ€ฆ
David Ha @DHpharmd
@DrJRMarcelin Public health and professional organizations can play a big role here changing public opinion around expectation of antibiotics. Our pharmacy students do this constantly through community outreach ๐Ÿ‘ #ASPchat
Jasmine R Marcelin, MD, FACP, FIDSA ๐Ÿฆ  @DrJRMarcelin
@DHpharmd #AntimicrobialStewardship town halls? #ASPchat
#ASPChat content from Twitter.